Alexander D. Hein - Gynecology

Author Information

Alexander D. Hein is an established researcher affiliated with the Department of Gynecology and Obstetrics at the University Endometriosis Center for Franconia, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, located in Erlangen, Germany. His research primarily focuses on gynecology, with a significant interest in pregnancy-related conditions, breast cancer, cervical cancer, and endometriosis.

Research Contributions

Alexander D. Hein has contributed extensively to the field of gynecology and obstetrics. His recent papers cover a range of topics including the prevalence of SARS-CoV-2 among pregnant women, the identification of risk loci for cervical cancer, and the treatment of pregnant and postpartum women requiring intensive care for COVID-19. He has also conducted research on mammographic density and breast cancer prognosis, genomic variants associated with cervical cancer risk, and the characterization of endometriosis patients. His work not only advances scientific understanding but also has practical implications for the treatment and management of various gynecological conditions.

Aliases

Alexander D. Hein is also known by several aliases including A Hein, A. Hein, and Alexander Hein.

Publication and Citation Metrics

Citation Count	10,689
h-index	45
Paper Count	193

Publications:

Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)

DOI: 10.1055/a-1727-9672

Year: 2022

Genome-wide association study and functional follow-up identifies 14q12 as a candidate risk locus for cervical cancer.

DOI: 10.1093/hmg/ddac031

Year: 2022

Pregnant and Postpartum Women Requiring Intensive Care Treatment for COVID-19—First Data from the CRONOS-Registry

DOI: 10.3390/jcm11030701

Year: 2022

Mammographic density and prognosis in primary breast cancer patients

DOI: 10.1016/j.breast.2021.06.004

Year: 2021

[COVID-19 and pregnancy].

DOI: 10.1007/s00129-021-04784-7

Year: 2021

Association of genomic variants at PAX8 and PBX2 with cervical cancer risk

DOI: 10.1002/ijc.33614

Year: 2021

Comparison of therapy benefit from standard anti-HER2 directed approaches in metastatic breast cancer (MBC) between initially HER2-positive patients and patients initially HER2-negative with switch to HER2-positive.

DOI: 10.1200/JCO.2021.39.15_SUPPL.1040

Year: 2021

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

DOI: 10.1007/s00428-021-03232-0

Year: 2021

Comprehensive characterization of endometriosis patients and disease patterns in a large clinical cohort

DOI: 10.1007/s00404-021-06200-w

Year: 2021

Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy

DOI: 10.1136/jitc-2021-002605

Year: 2021

Why is CBT Relevant in Gynecology?

How is HRT Administered?

Can Hormonal Imbalance Affect Fertility?

How Can Polycystic Ovary Syndrome (PCOS) Influence Sleep?

What Happens to Breast Tissue During Menopause?

What is Laparoscopic Assisted Vaginal Hysterectomy (LAVH)?

How Can Straining Be Prevented?

What is Genetic Counseling?

What is Persistent Pain in Gynecology?

Who Are Midwives?

Partnered Content Networks

Relevant Topics